microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer
Sign Up to like & getrecommendations! Published in 2019 at "BMC Cancer"
DOI: 10.1186/s12885-019-5620-6
Abstract: BackgroundOne-third of cervical cancer patients are still diagnosed at advanced stages. The five-year survival rate is decreased in about 50% of advanced stage cervical cancer patients worldwide, and the clinical outcomes are remarkably varied and… read more here.
Keywords: cervical cancer; 944 cervical; expression levels; cancer ... See more keywords